Please login to the form below

Not currently logged in
Email:
Password:

Contract research organisation PRA opens Singapore office

Continues its Asia-Pacific expansion with new centralised operations base

PRA has opened a new office in Singapore that will act as a centralised operations base for its activities in the region.

The US contract research organisation's new facility will provide monitoring, project management, safety reporting, feasibility and other services.

Helen Neal, PRA's director of clinical operations for Asia-Pacific, said: "Building our capability across the region with the centre in Singapore permits our sponsors to experience a wider range of services and expertise.

"This location provides our teams with access to experts and resources within their time zone, positively impacting our speed and quality of delivery on projects."

PRA has been steadily expanding its Asia-Pacific operations since 2000 and its operations in the region also include Korea, Taiwan, China, Hong Kong, Thailand, Australia, New Zealand, and India.

The expansion mirrors investments from the pharma industry in new research operations. Last year Merck & Co pledged $1.5bn to expand its presence in China and Bayer said it expects Asia to account for €11bn of sales by 2015.

24th February 2012

Share

Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Uptake Strategies

We are a specialist healthcare marketing consultancy generating competitive strategies underpinned with excellent customer insight, clear objectives and measures of...

Latest intelligence

Online Physician Communities
Review: diabetes tweetchat
Some of the key points from the recent #M3diabetes tweetchat held by PMLiVE and M3 Europe...
access denied
Sales reps struggle to access doctors
Doctors continue to turn away from face-to-face visits from pharma sales reps and look instead towards mobile technology for information...
Online Physician Communities
Research finds doctors are optimistic about new diabetes drugs but concerned over rationing
New data from M3 Global Research shows that clinicians buy in to the effectiveness of new diabetes therapies. However, they are concerned about rationing and believe that more resources are...